Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation

Colorectal Disease

Volumn 15, Issue 6, 2013, Pages 674-682

  Perez, R O ^a,b   Habr Gama, A ^a   Sao Juliao G P ^b   Proscurshim, I ^a   Ono, C R ^b,c   Lynn, P ^a   Bailao Aguilar P ^a   Nahas, S C ^b   Gama Rodrigues, J ^a   Buchpiguel, C A ^b,c  

^a Angelita and Joaquim Gama Institute   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital do Coracao   (Brazil)

Author keywords

Inguinal nodes; Neoadjuvant therapy; PET CT; Rectal cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; OXALIPLATIN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INGUINAL LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; FLUOROURACIL; HUMANS; INGUINAL CANAL; LYMPH NODES; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84879512726     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12159     Document Type: Article

References (16)

1. Hamano T, Homma Y, Otsuki Y, Shimizu S, Kobayashi H, Kobayashi Y. Inguinal lymph node metastases are recognized with high frequency in rectal adenocarcinoma invading the dentate line. The histological features at the invasive front may predict inguinal lymph node metastasis. Colorectal Dis 2010; 12: e200-5.
2. Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-40.
3. Myerson RJ, Garofalo MC, El Naqa I et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 2009; 74: 824-30.
4. Luna-Perez P, Corral P, Labastida S, Rodriguez-Coria D, Delgado S. Inguinal lymph node metastases from rectal adenocarcinoma. J Surg Oncol 1999; 70: 177-80.
5. Mesko TW, Rodriguez-Bigas MA, Petrelli NJ. Inguinal lymph node metastases from adenocarcinoma of the rectum. Am J Surg 1994; 168: 285-7.
6. Tocchi A, Lepre L, Costa G et al. Rectal cancer and inguinal metastases: prognostic role and therapeutic indications. Dis Colon Rectum 1999; 42: 1464-6.
7. Bardia A, Greeno E, Miller R et al. Is a solitary inguinal lymph node metastasis from adenocarcinoma of the rectum really a metastasis? Colorectal Dis 2010; 12: 312-5.
8. Davey K, Heriot AG, Mackay J et al. The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer. Dis Colon Rectum 2008; 51: 997-1003.
9. Perez RO, Habr-Gama A, Gama-Rodrigues J et al. Accuracy of PET/CT and Clinical Assessment in the Detection of Complete Rectal Tumor Regression following Neoadjuvant Chemoradiation. Long-term results of a prospective trial (NCT00254683). Cancer 2012; 118: 3501-11.
10. Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, Gama-Rodrigues J. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum 2010; 53: 1692-8.
11. Habr-Gama A, Perez RO, Nadalin W et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004; 240: 711-7; discussion 7-8.
12. Francois Y, Nemoz CJ, Baulieux J et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999; 17: 2396.
13. Kalady MF, de Campos-Lobato LF, Stocchi L et al. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg 2009; 250: 582-9.
14. Damin DC, Tolfo GC, Rosito MA, Spiro BL, Kliemann LM. Sentinel lymph node in patients with rectal cancer invading the anal canal. Tech Coloproctol 2010; 14: 133-9.
15. Krengli M, Milia ME, Turri L et al. FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma. Radiat Oncol 2010; 5: 10.
16. Mistrangelo M, Pelosi E, Bello M et al. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer. Int J Radiat Oncol Biol Phys 2010; 77: 73-8.